retatrutide ly3437943 phase 2 trial obesity nejm 2023 🧬 R3TA is a next-generation peptide being studied for its unique triple-receptor approach to metabolic health. Unlike traditional GLP-1 therapies, R3TA is designed to interact with three metabolic pathways simultaneously: GLP-1, GIP Retatrutide (LY3437943), a Novel GIP/GLP-1/Glucagon

CMN lesions can appear as small spots or as very large patches covering entire regions of skin, such as the face, back, or neck

Satish-Kumar, M., Mrudula, T., Mitra, N

(2000) study in adult female rats demonstrated that Ipamorelin administration increased bone mineral content and periosteal bone formation markers without the concurrent cortisol and prolactin elevations observed with other GHRPs, providing early evidence that Ipamorelin's selective GH elevation could drive anabolic skeletal effects through a cleaner endocrine profile

New Phytol 181(1):103114

Magnesium is a natural muscle relaxant that also draws water into the intestines